Evidence map›Paper›PMID 38203674›Full record

ArticleInternational journal of molecular sciences2023

Concordance between the In Vivo Content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and Blood in Patients with Epilepsy.

Maria A Tikhonova, Anna A Shvaikovskaya, Svetlana Y Zhanaeva, Galina I Moysak, Anna A Akopyan, Jamil A Rzaev, Konstantin V Danilenko, Lyubomir I Aftanas

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria A TikhonovaScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.ORCID 0000-0002-4265-8981
Anna A ShvaikovskayaScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.
Svetlana Y ZhanaevaScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.ORCID 0000-0002-4798-054X
Galina I MoysakFSBI "Federal Center for Neurosurgery", 630087 Novosibirsk, Russia.
Anna A AkopyanScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.
Jamil A RzaevFSBI "Federal Center for Neurosurgery", 630087 Novosibirsk, Russia.ORCID 0000-0002-1209-8960
Konstantin V DanilenkoScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.ORCID 0000-0002-2096-4216
Lyubomir I AftanasScientific Research Institute of Neurosciences and Medicine (SRINM), 630117 Novosibirsk, Russia.
Federal Neurosurgical Center Novosibirsk · RU

Funding

Russian Science Foundation 22-25-00588
6 · The paper itself

Abstract

The identification of reliable brain-specific biomarkers in periphery contributes to better understanding of normal neurophysiology and neuropsychiatric diseases. The neurospecific proteins BDNF, NSE, VILIP-1, and S100B play an important role in the pathogenesis of neuropsychiatric disorders, including epilepsy. This study aimed to assess the correspondence of the expression of BDNF, NSE, VILIP-1, and S100B in the blood (serum and peripheral blood mononuclear cells (PBMCs)) to the in vivo hippocampal levels of subjects with drug-resistant epilepsy who underwent neurosurgery (N = 44) using multiplex solid-phase analysis, ELISA, and immunohistochemical methods, as well as to analyze the correlations and associations of the blood and hippocampal levels of these proteins with clinical parameters. We first studied the concordance between in vivo brain and blood levels of BDNF, NSE, VILIP-1, and S100B in epileptic patients. A positive correlation for NSE between hippocampal and PBMC levels was revealed. NSE levels in PBMCs were also significantly correlated with average seizure duration. BDNF levels in PBMCs were associated with seizure frequency and hippocampal sclerosis. Thus, NSE and BDNF levels in PBMCs may have potential as clinically significant biomarkers. Significant correlations between the levels of the neurospecific proteins studied herein suggest interactions between BDNF, NSE, VILIP-1, and S100B in the pathophysiology of epilepsy.

Indexed as

Brain-Derived Neurotrophic FactorEpilepsyBiomarkersHippocampusHumansLeukocytes, MononuclearS100 Calcium Binding Protein beta SubunitSeizuresBiomarkersBrain-Derived Neurotrophic FactorS100B protein, humanS100 Calcium Binding Protein beta Subunitbrainhippocampal sclerosishumanimmunoassayimmunohistochemical analysismesial temporal lobe epilepsyneurosurgeryperipheral mononuclear blood cellsserum

Identifiers

PMID38203674
PMCPMC10779095
OpenAlexW4390403357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.